Schwab Gisela 4
4 · EXELIXIS, INC. · Filed Jul 23, 2021
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
Schwab Gisela
EVP & Chief Medical Officer
Transactions
- Exercise/Conversion
Option (right to buy)
2021-07-21−35,000→ 40,000 totalExercise: $4.20From: 2017-02-11Exp: 2023-02-10→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2021-07-21$4.20/sh+35,000$147,000→ 649,078 total
Holdings
- 14,880(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Includes 243,968 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F2]Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of July 20, 2021.
- [F3]The option, representing the right to purchase a total of 75,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 11, 2020.